The Effects of Surgery Type and Chemotherapy on Early-Stage Breast Cancer Patients’ Quality of Life Over 2-Year Follow-up

详细信息    查看全文

• 作者：Donna B. Jeffe PhD ; Maria Pérez MA ; Emily F. Cole MD…
• 刊名：Annals of Surgical Oncology
• 出版年：2016
• 出版时间：March 2016
• 年：2016
• 卷：23
• 期：3
• 页码：735-743
• 全文大小：504 KB
• 参考文献：1.Virning BA, Tuttle TM, Shamliyan T, Kane RL. Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes. J Natl Cancer Inst. 2010;102:170–8.CrossRef
  2.Houghton J, George WD, Cuzick J, Duggan C, Fentiman IS, Spittle M, et al. Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomised controlled trial. Lancet. 2003;362:95–102.CrossRef PubMed
  3.Morrow M, Strom EA, Bassett LW, Dershaw DD, Fowble B, Harris JR, et al. Standard for the management of ductal carcinoma in situ of the breast (DCIS). CA Cancer J Clin. 2002;52:256–76.CrossRef PubMed
  4.Silverstein MJ, Barth A, Poller DN, Gierson ED, Colburn WJ, Waisman JR, et al. Ten year results comparing mastectomy to excision and radiotherapy for ductal carcinoma in situ of the breast. Eur J Cancer. 1995;31A:1425–7.CrossRef PubMed
  5.Bartelink H, Horiot JC, Poortmans P, Struikmans H, Van den Bogaert W, Barillot I, et al. Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Engl J Med. 2001;345:1378–87.CrossRef PubMed
  6.Elder EE, Kennedy CW, Gluch L, Carmalt HL, Janu NC, Joseph MG, et al. Patterns of breast cancer relapse. Eur J Surg Oncol. 2006;32:922–7.CrossRef PubMed
  7.Burstein HJ, Polyak K, Wong JS, Lester SC, Kaelin CM. Ductal carcinoma in situ of the breast. N Engl J Med. 2004;350:1430–41.CrossRef PubMed
  8.Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, et al. Twenty-year follow-up of a randomized study comparing total mastectomy, lumpectomy and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347:1233–41.CrossRef PubMed
  9.Poggi MM, Danforth DN, Sciuto LC, Smith SL, Steinberg SM, Liewehr DJ, et al. Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy: the National Cancer Institute Randomized Trial. Cancer. 2003;98:697–702.CrossRef PubMed
  10.Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;366:2087–106.CrossRef
  11.President’s Cancer Panel, US Department of Health and Human Services, National Institutes of Health, National Cancer Institute. Living beyond cancer: finding a new balance. http://​deainfo.​nci.​nih.​gov/​advisory/​pcp/​annualReports/​pcp03-04rpt/​Survivorship.​pdf . Accessed 3 Dec 2014.
  12.Ganz PA, Rowland JH, Meyerowitz BE, Desmond KA. Impact of different adjuvant therapy strategies on quality of life in breast cancer survivors. Recent Results Cancer Res. 1998;152:396–411.CrossRef PubMed
  13.Ganz PA, Kwan L, Stanton AL, Bower JE, Belin TR. Physical and psychosocial recovery in the year after primary treatment of breast cancer. J Clin Oncol. 2011;29:1101–9.PubMedCentral CrossRef PubMed
  14.Amichetti M, Caffo O, Arcicasa M, Roncadin M, Lora O, Rigon A, et al. Quality of life in patients with ductal carcinoma in situ of the breast treated with conservative surgery and postoperative irradiation. Breast Cancer Res Treat. 1999;54:109–15.CrossRef PubMed
  15.Claus E, Petruzella S, Carter D, Kasl S. Quality of life for women diagnosed with breast carcinoma in situ. J Clin Oncol. 2006;24:4875–81.CrossRef PubMed
  16.Ganz PA, Rowland JH, Desmond K, Meyerowitz BE, Wyatt GE. Life after breast cancer: understanding women’s health-related quality of life and sexual functioning. J Clin Oncol. 1998;16:501–14.PubMed
  17.Klein D, Mercier M, Abeilard E, Puyraveau M, Danzon A, Dalstein V, et al. Long-term quality of life after breast cancer: a French registry-based controlled study. Breast Cancer Res Treat. 2011;129:125–34.CrossRef PubMed
  18.Paskett ED, Alfano CM, Davidson MA, Andersen BL, Naughton MJ, Sherman A, et al. Breast cancer survivors’ health-related quality of life. Cancer. 2008;113:3222–30.PubMedCentral CrossRef PubMed
  19.Paskett ED, Herndon JE, Day JM, Stark NN, Winer EP, Grubbs SS, et al. Applying a conceptual model for examining health-related quality of life in long-term breast cancer survivors: CALGB study 79804. Psychooncology. 2008;17:1108–20.PubMedCentral CrossRef PubMed
  20.Trentham-Dietz A, Sprague BL, Klein R, Klein BEK, Cruickshanks KJ, Fryback DG, et al. Health-related quality of life before and after a breast cancer diagnosis. Breast Cancer Res Treat. 2008;109:379–87.CrossRef PubMed
  21.van Gestel YR, Voogd AC, Vingerhoets AJ, Mols F, Nieuwenhuijzen GA, van Driel OJ, et al. A comparison of quality of life, disease impact and risk perception in women with invasive breast cancer and ductal carcinoma in situ. Eur J Cancer. 2007;43:549–56.CrossRef PubMed
  22.Fallowfield LJ, Hall A, Maguire GP, Baum M. Psychological outcomes of different treatment policies in women with early breast cancer outside a clinical trial. BMJ. 1990;301:575–80.PubMedCentral CrossRef PubMed
  23.Ganz PA, Schag CA, Lee JJ, Polinsky ML, Tan SJ. Breast conservation versus mastectomy: is there a difference in psychological adjustment or quality of life in the year after surgery? Cancer. 1992;69:1729–38.CrossRef PubMed
  24.Pozo C, Carver CS, Noriega V, Harris SD, Robinson DS, Ketcham AS, et al. Effects of mastectomy versus lumpectomy on emotional adjustment to breast cancer: a prospective study of the first year postsurgery. J Clin Oncol. 1992;10:1292–8.PubMed
  25.Dorval M, Maunsell E, Deschenes L, Brisson J, Masse B. Long-term quality of life after breast cancer: comparison of 8-year survivors with population controls. J Clin Oncol. 1998;16:487–94.PubMed
  26.Shimozuma K, Ganz PA, Petersen L, Hirji K. Quality of life in the first year after breast cancer surgery: Rehabilitation needs and patterns of recovery. Breast Cancer Res Treat. 1999;56:45–57.CrossRef PubMed
  27.Janni W, Rjosk D, Dimpfl TH, Haertl K, Strobl B, Hepp F, et al. Quality of life influenced by primary surgical treatment for stage I–III breast cancer: Long-term follow-up of a matched-pair analysis. Ann Surg Oncol. 2001;8:542–8.PubMed
  28.Nissen MJ, Swenson KK, Ritz LJ, Farrell JB, Sladek ML, Lally RM. Quality of life after breast carcinoma surgery: a comparison of three surgical procedures. Cancer. 2001;91:1238–46.CrossRef PubMed
  29.Nano MT, Grantly G, Kollias J, Bochner MA, Malycha P, Winefield HR. Psychological impact and cosmetic outcome of surgical breast cancer strategies. ANZ J Surg. 2005;75:940–7.CrossRef PubMed
  30.Kennedy F, Harcourt D, Rumsey N, White P. The psychosocial impact of ductal carcinoma in situ (DCIS): a longitudinal prospective study. Breast. 2010;19:382–7.CrossRef PubMed
  31.He Z-Y, Tong Q, Wu S-G, Li F-Y, Lin H-X, Guan X-X. A comparison of quality of life and satisfaction of women with early-stage breast cancer treated with breast conserving therapy vs mastectomy in southern China. Support Care Cancer. 2012;20:2441–9.CrossRef PubMed
  32.Jeffe DB, Pérez M, Liu Y, Collins KK, Aft RL, Schootman M. Quality of life changes over time in women diagnosed with ductal carcinoma in situ, early-stage invasive breast cancer, and age-matched controls. Breast Cancer Res Treat. 2012;134:379–91.PubMedCentral CrossRef PubMed
  33.Lauzier S, Maunsell E, Levesque P, Mondor M, Robert J, Robidoux A, Provencher L. Psychological distress and physical health in the year after diagnosis of DCIS or invasive breast cancer. Breast Cancer Res Treat. 2010;120:685–91.CrossRef PubMed
  34.Ganz PA. Late effects of cancer and its treatment. Semin Oncol Nurs. 2001;17:241–8.CrossRef PubMed
  35.Ganz PA, Coscarelli A, Fred C, Kahn B, Polinsky ML, Petersen L. Breast cancer survivors: psychosocial concerns and quality of life. Breast Cancer Res Treat. 1996;38:183–99.CrossRef PubMed
  36.Ganz PA, Land SR, Geyer CE, Cecchini RS, Costantino JP, Pajon ER, et al. Menstrual history and quality-of-life outcomes in women with node-positive breast cancer treated with adjuvant therapy on the NSABP B-30 trial. J Clin Oncol. 2011;29:1110–6.PubMedCentral CrossRef PubMed
  37.Katzman R, Brown T, Fuld P, Peck A, Schechter R, Schimmel H. Validation of a short Orientation-Memory-Concentration test of cognitive impairment. Am J Psychiatry. 1983;140:734–9.CrossRef PubMed
  38.Brady MJ, Cella DF, Mo F, Bonomi AE, Tulsky DS, Lloyd SR, et al. Reliability and validity of the functional assessment of cancer therapy
  east quality of life instrument. J Clin Oncol. 1997;15:974–86.PubMed
  39.Sherbourne CD, Stewart AL. The MOS social support survey. Soc Sci Med. 1991;32:705–14.CrossRef PubMed
  40.Katz JN, Chang LC, Sangha O, Fossel AH, Bates DW. Can comorbidity be measured by questionnaire rather than medical record review? Medical Care. 1996;34:73–84.CrossRef PubMed
  41.Charlson ME, Pompei P, Ales K, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis. 1987;40:373–83.CrossRef PubMed
  42.Pérez M, Liu Y, Schootman M, Aft RL, Schechtman KB, Gillanders WE, Jeffe DB. Changes in sexual problems over time in women with and without early-stage breast cancer. Menopause. 2010;17:924–37.PubMedCentral CrossRef PubMed
  43.Collins K, Liu Y, Schootman M, Aft R, Yan Y, Dean G, et al. Effects of breast cancer surgery and surgical side effects on body image over time. Breast Cancer Res Treat. 2011;126:167–76.PubMedCentral CrossRef PubMed
  44.Whelan TJ, Levine M, Julian J, Kirkbride P, Skingley P. The effects of radiation therapy on quality of life of women with breast carcinoma: results of a randomized trial. Ontario Clinical Oncology Group. Cancer. 2000;88:2260–6.CrossRef PubMed
  45.Garsa AA, Ferraro DJ, DeWees TA, Deshields TL, Margenthaler JA, Cyr AE, et al. A prospective longitudinal clinical trial evaluating quality of life after breast-conserving surgery and high-dose-rate interstitial brachytherapy for early-stage breast cancer. Int J Radiat Oncol Biol Phys. 2013;87:1043–50.PubMedCentral CrossRef PubMed
  46.Härtl K, Janni W, Kastner R, Sommer H, Strobl B, Rack B, Stauber M. Impact of medical and demographic factors on long-term quality of life and body image of breast cancer patients. Ann Oncol. 2003;14:1064–71.CrossRef PubMed
  47.Engel J, Kerr J, Schlesinger-Raab A, Sauer H, Holzel D. Quality of life following breast-conserving therapy or mastectomy: results of a 5-year prospective study. Breast J. 2004;10:223–31.CrossRef PubMed
  48.Arndt V, Stegmaier C, Ziegler H, Brenner H. Quality of life over 5 years in women with breast cancer after breast-conserving therapy versus mastectomy: a population-based study. J Cancer Res Clin Oncol. 2008;134:1311–8.CrossRef PubMed
  49.Han J, Grothuesmann D, Neises M, Hille U, Hillemanns P. Quality of life and satisfaction after breast cancer operation. Arch Gynecol Obstet. 2010;282:75–82.CrossRef PubMed
  50.Taira N, Shimozuma K, Shiroiwa T, Ohsumi S, Kuroi K, Saji S, et al. Associations among baseline variables, treatment-related factors and health-related quality of life 2 years after breast cancer surgery. Breast Cancer Res Treat. 2011;128:735–47.CrossRef PubMed
  51.Casso D, Buist DS, Taplin S. Quality of life of 5–10 year breast cancer survivors diagnosed between age 40 and 49. Health Qual Life Outcomes. 2004;2:25.PubMedCentral CrossRef PubMed
  52.Ganz PA, Desmond KA, Leedham B, Rowland JH, Meyerowitz BE, Belin TR. Quality of life in long-term, disease-free survivors of breast cancer: a follow-up study. J Natl Cancer Inst. 2002;94:39–49.CrossRef PubMed
  53.Versmessen H, Vinh-Hung V, Van Parijs H, Miedema G, Voordeckers M, Adriaenssens N, et al. Health-related quality of life in survivors of stage I-II breast cancer: randomized trial of post-operative conventional radiotherapy and hypofractionated tomotherapy. BMC Cancer. 2012;12:495–511.PubMedCentral CrossRef PubMed
  54.Arora NK, Gustafson DH, Hawkins RP, McTavish F, Cella DF, Pingree S, et al. Impact of surgery and chemotherapy on the quality of life of younger women with breast carcinoma: a prospective study. Cancer. 2001;92:1288–98.CrossRef PubMed
  55.Browall M, Ahlberg K, Karlsson P, Danielson E, Persson LO, Gaston-Johansson F. Health-related quality of life during adjuvant treatment for breast cancer among postmenopausal women. Eur J Oncol Nurs. 2008;12:180–9.CrossRef PubMed
  56.Noal S, Levy C, Hardouin A, Rieux C, Heutte N, Ségura C, et al. One-year longitudinal study of fatigue, cognitive functions, and quality of life after adjuvant radiotherapy for breast cancer. Int J Radiat Oncol Biol Phys. 2011;81:795–803.CrossRef PubMed
  57.Land SR, Wickerham DL, Costantino JP, Ritter MW, Vogel VG, Lee M, et al. Patient-reported symptoms and quality of life during treatment with tamoxifen or raloxifene for breast cancer prevention: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial. JAMA. 2006;295:2742–51.CrossRef PubMed
  58.Goss PE, Ingle JN, Alés-Martínez JE, Cheung AM, Chlebowski RT, Wactawski-Wende J, et al. Exemestane for breast-cancer prevention in postmenopausal women. N Engl J Med. 2011;364:2381–91.CrossRef PubMed
  59.Takei H, Ohsumi S, Shimozuma K, Takehara M, Suemasu K, Ohashi Y, Hozumi Y. Health-related quality of life, psychological distress, and adverse events in postmenopausal women with breast cancer who receive tamoxifen, exemestane, or anastrozole as adjuvant endocrine therapy: National Surgical Adjuvant Study of Breast Cancer 04 (N-SAS BC 04). Breast Cancer Res Treat. 2012;133:227–36.CrossRef PubMed
  60.van Nes JG, Fontein DB, Hille ET, Voskuil DW, van Leeuwen FE, de Haes JC, et al. Quality of life in relation to tamoxifen or exemestane treatment in postmenopausal breast cancer patients: a Tamoxifen Exemestane Adjuvant Multinational (TEAM) Trial side study. Breast Cancer Res Treat. 2012;134:267–76.PubMedCentral CrossRef PubMed
  61.Burgess C, Cornelius V, Love S, Graham J, Richards M, Ramirez A. Depression and anxiety in women with early breast cancer: five year observational cohort study. Br Med J. 2005;330:702–5.CrossRef
  62.Eton DT, Cella D, Yost KJ, Yount SE, Peterman AH, Neuberg DS, et al. A combination of distribution- and anchor-based approaches determined minimally important differences (MIDs) for four endpoints in a breast cancer scale. J Clin Epidemiol. 2004;57:898–910.CrossRef PubMed
  63.Gajdos C, Tartter PI, Bleiweiss IJ. Lymphatic invasion, tumor size, and age are independent predictors of axillary lymph node metastases in women with T1 breast cancers. Ann Surg. 1999;230:692–6.PubMedCentral CrossRef PubMed
  64.Temple LK, Baron R, Cody HS III, Fey JV, Thaler HT, Borgen PI, et al. Sensory morbidity after sentinel lymph node biopsy and axillary dissection: a prospective study of 233 women. Ann Surg Oncol. 2002;9:654–62.CrossRef PubMed
  65.Kootstra JJ, Hoekstra-Weebers JEHM, Rietman JS, de Vries J, Baas PC, Geertzen JHB, Hoekstra HJ. A longitudinal comparison of arm morbidity in stage I–II breast cancer patients treated with sentinel lymph node biopsy, sentinel lymph node biopsy followed by completion lymph node dissection, or axillary lymph node dissection. Ann Surg Oncol. 2010;17:2384–94.PubMedCentral CrossRef PubMed
  66.Langer I, Guller U, Berclaz G, Koechli OR, Schaer G, Fehr MK, et al. Morbidity of sentinel lymph node biopsy (SLN) alone versus SLN and completion axillary lymph node dissection after breast cancer surgery: a prospective Swiss Multicenter Study on 659 patients. Ann Surg. 2007;245:452–61.PubMedCentral CrossRef PubMed
  
• 作者单位：Donna B. Jeffe PhD (1) (2)
  Maria Pérez MA (1)
  Emily F. Cole MD (3)
  Ying Liu MD, PhD (4)
  Mario Schootman PhD (5)
  
  1. Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA
  2. Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, St. Louis, MO, USA
  3. Department of Internal Medicine, University of Missouri School of Medicine, Columbia, MO, USA
  4. Department of Surgery, Washington University School of Medicine, St. Louis, MO, USA
  5. College for Public Health and Social Justice, Saint Louis University, St. Louis, MO, USA
  
• 刊物主题：Surgical Oncology; Oncology; Surgery;
• 出版者：Springer US
• ISSN：1534-4681

文摘

Background We examined the effects of surgery type and adjuvant chemotherapy on change in early-stage breast cancer patients’ quality of life (QOL) over time.